A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
University of Chicago
University of Chicago
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Institute of Hematology & Blood Diseases Hospital, China
OHSU Knight Cancer Institute
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
University of Michigan Rogel Cancer Center
St. Jude Children's Research Hospital
Nantes University Hospital
Dana-Farber Cancer Institute
University of Illinois at Chicago
Stanford University
University of Chicago
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ruijin Hospital
Institute of Hematology & Blood Diseases Hospital, China
Goethe University
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Institute of Hematology & Blood Diseases Hospital, China
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
City of Hope Medical Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
University of California, San Diego
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Therapeutic Advances in Childhood Leukemia Consortium
Dana-Farber Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
Instituto do Cancer do Estado de São Paulo